Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Tianyin Pharma Completes Antibiotic Facility

publication date: Jan 28, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Tianyin Pharmaceutical completed construction of its Jiangchuan macrolide facility in the Xinjin Industrial Development Area, near Chengdu, China. The company says it expects the plant to add revenues during its 2011 fiscal year. In its Phase I state, the facility is capable of producing up to 240 tons of azithromycin API for domestic and international markets. More details....

Stock Symbol: (NYSE Amex: TPI)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners